MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
364.41%
Quick Ratio
326.78%
Cash Ratio
264.51%
Debt to Asset Ratio
44.35%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Property, plant and equipment, n...
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other payab...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
4,791,676 4,547,530 4,036,868
Accounts receivable, net
938,019 865,080 863,281
Inventories, net
681,590 608,227 531,687
Prepaid expenses and other current assets
189,995 212,752 232,641
Total current assets
6,601,280 6,233,589 5,664,477
Land
NaN 71,434 NaN
Building
NaN 1,187,836 NaN
Machinery And Equipment
NaN 273,769 NaN
Laboratory Equipment
NaN 309,471 NaN
Software And Software Development Costs
NaN 124,136 NaN
Leasehold Improvements
NaN 76,568 NaN
Property and equipment, at cost
NaN 2,043,214 NaN
Less accumulated depreciation
NaN 528,695 NaN
Construction in progress
NaN 127,159 NaN
Property, plant and equipment, net
1,640,918 1,641,678 1,628,114
Operating lease right-of-use assets
145,497 148,184 140,217
2026 (remainder of year)
6,045 NaN 2,090
2027-Cost Of Sales
7,994 NaN 8,272
2027-Selling General And Administrative Expenses
67 NaN 67
2027
8,061 6,293 8,339
2027-Cost Of Sales
NaN 6,226 NaN
2027-Selling General And Administrative Expenses
NaN 67 NaN
2028
8,061 6,293 8,339
2028
NaN 6,293 NaN
2030
8,061 6,293 8,339
2031 and thereafter
23,392 31,239 28,135
Intangible assets, net
61,681 62,704 63,581
Other non-current assets
104,243 102,418 136,197
Total non-current assets
1,952,339 1,954,984 1,968,109
Total assets
8,553,619 8,188,573 7,632,586
Accounts payable
423,546 479,035 383,676
Accrued expenses and other payables
1,079,283 1,109,120 1,001,661
Tax payable
63,522 41,625 11,219
Operating lease liabilities, current portion
20,584 20,698 15,732
Research and development cost share liability, current portion
35,700 64,345 90,596
Sale of future royalty liability, current portion
72,735 56,714 52,245
Short-term debt
116,140 57,293 813,296
Total current liabilities
1,811,510 1,828,830 2,368,425
Long-term debt
962,515 961,913 139,571
Sale of future royalty liability, non-current portion
831,664 850,242 832,755
Operating lease liabilities, non-current portion
49,670 52,940 51,387
Deferred tax liabilities
55,866 53,209 47,066
Research and development cost share liability, non-current portion
NaN 0 0
Other long-term liabilities
81,952 80,245 64,056
Total non-current liabilities
1,981,667 1,998,549 1,134,835
Total liabilities
3,793,177 3,827,379 3,503,260
Ordinary shares, 0.0001 par value per share 1,540,975,898 and 1,540,975,898 shares issued and 1,444,479,378 and 1,441,075,618 shares outstanding as of march 31, 2026 and december 31, 2025, respectively
144 144 144
Additional paid-in capital
12,906,326 12,759,137 12,616,844
Accumulated other comprehensive loss
-53,482 -78,184 -101,257
Accumulated deficit
-8,092,546 -8,319,903 -8,386,405
Total shareholders equity
4,760,442 4,361,194 4,129,326
Total liabilities and shareholders equity
8,553,619 8,188,573 7,632,586
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

2031 and thereafter$23,392K 2030$8,061K 2028$8,061K 2027$8,061K 2027-Cost Of Sales$7,994K 2026 (remainder ofyear)$6,045K 2027-Selling General AndAdministrative Expenses$67K Cash and cashequivalents$4,791,676K Accounts receivable, net$938,019K Inventories, net$681,590K Prepaid expenses andother current assets$189,995K Property, plant andequipment, net$1,640,918K Operating leaseright-of-use assets$145,497K Other non-currentassets$104,243K Intangible assets, net$61,681K Total current assets$6,601,280K Total non-currentassets$1,952,339K Total assets$8,553,619K Total liabilities andshareholders equity$8,553,619K Total shareholdersequity$4,760,442K Total liabilities$3,793,177K Accumulated deficit-$8,092,546K Accumulated othercomprehensive loss-$53,482K Additional paid-in capital$12,906,326K Total non-currentliabilities$1,981,667K Total currentliabilities$1,811,510K Ordinary shares, 0.0001par value per share...$144K Long-term debt$962,515K Sale of futureroyalty liability,...$831,664K Other long-termliabilities$81,952K Deferred tax liabilities$55,866K Operating leaseliabilities, non-current...$49,670K Accrued expenses andother payables$1,079,283K Accounts payable$423,546K Short-term debt$116,140K Sale of futureroyalty liability,...$72,735K Tax payable$63,522K Research and developmentcost share...$35,700K Operating leaseliabilities, current portion$20,584K

BeOne Medicines Ltd. (ONC)

BeOne Medicines Ltd. (ONC)